This product is not a drug, food, cosmetic, or dietary supplement, has not been evaluated or approved by the FDA, and is not intended to diagnose, treat, cure or prevent any disease
The STEP-4 trial (Rubino et al., JAMA , 2021) studied this directly: patients who reached goal weight on 2.4 mg were randomized to continue 2.4 mg vs switch to placebo
They are easy to use, require daily application, and can be combined with other ingredients to improve follicle health
Although body mass index data were not available for this cohort, our findings suggest that any unmeasured obesity is likely to have been more prevalent in the GLP1 receptor agonist group, with any associated bias potentially moving the estimate towards increased risk of thyroid cancer
A little tiredness is common, but extreme fatigue may be worth discussing
Drawing 8 units (for example, 2 mg at 25 mg/mL concentration) requires estimating between the 8-unit and 10-unit marks